NCT00547131View on ClinicalTrials.gov

Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2009

Conditions
Brain and Central Nervous System TumorsMetastatic Cancer
Interventions
DRUG

temozolomide

OTHER

laboratory biomarker analysis

OTHER

liquid chromatography

OTHER

mass spectrometry

OTHER

pharmacological study

PROCEDURE

conventional surgery

RADIATION

stereotactic radiosurgery

Trial Locations (2)

91105

City of Hope Medical Group, Pasadena

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00547131 - Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors | Biotech Hunter | Biotech Hunter